Primary hypothyroidism and 131I-MIBG therapy In neuroblastoma
- 3 July 1993
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 342 (8862) , 57
- https://doi.org/10.1016/0140-6736(93)91925-c
Abstract
No abstract availableKeywords
This publication has 3 references indexed in Scilit:
- 131-I-Metaiodobenzylguanidine Treatment in Patients with Refractory Advanced NeuroblastomaAmerican Journal of Clinical Oncology, 1992
- Treatment of advanced neuroblastoma with i-131 meta-iodobenzylguanidineCancer, 1991
- Metaiodobenzylguanidine (mIBG) in treatment of 47 patients with neuroblastoma: Results of the German neuroblastoma trialMedical and Pediatric Oncology, 1991